請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72244
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林靖愉 | |
dc.contributor.author | Shang-Ting Lin | en |
dc.contributor.author | 林尚廷 | zh_TW |
dc.date.accessioned | 2021-06-17T06:31:00Z | - |
dc.date.available | 2023-08-30 | |
dc.date.copyright | 2018-08-30 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-16 | |
dc.identifier.citation | 1. Xing Y, Xu Y, Shi M, Lian Y: The impact of PM2.5 on the human respiratory system. Journal of Thoracic Disease 2016, 8(1):E69-E74.
2. Kim KH, Jahan SA, Kabir E, Brown RJ: A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects. Environment international 2013, 60:71-80. 3. Li C, Ro Y: Indoor characteristics of polycyclic aromatic hydrocarbons in the urban atmosphere of Taipei. Atmospheric Environment 2000, 34(4):611-620. 4. Daisey JM, Spengler JD, Kaarakka P: A comparison of the organic chemical composition of indoor aerosols during woodburning aero non-woodburning periods. Environment international 1989, 15(1):435-442. 5. Offermann FJ, Loiselle SA, Hodgson AT, Gundel LA, Daisey JM: A Pilot Study to Measure Indoor Concentrations and Emission Rates of Polycyclic Aromatic Hydrocarbons. Indoor Air 1991, 1(4):497-512. 6. Van Winkle LS, Johnson ZA, Nishio SJ, Brown CD, Plopper CG: Early events in naphthalene-induced acute Clara cell toxicity: comparison of membrane permeability and ultrastructure. American journal of respiratory cell and molecular biology 1999, 21(1):44-53. 7. West JAA, Pakehham G, Morin D, Fleschner CA, Buckpitt AR, Plopper CG: Inhaled Naphthalene Causes Dose Dependent Clara Cell Cytotoxicity in Mice but Not in Rats. Toxicology and Applied Pharmacology 2001, 173(2):114-119. 8. Mahvi D, Bank H, Harley R: Morphology of a naphthalene-induced bronchiolar lesion. The American Journal of Pathology 1977, 86(3):558-572. 9. Plopper CG, Cranz DL, Kemp L, Serabjit-Singh CJ, Philpot RM: Immunohistochemical demonstration of cytochrome P-450 monooxygenase in Clara cells throughout the tracheobronchial airways of the rabbit. Experimental lung research 1987, 13(1):59-68. 10. Plopper CG, Suverkropp C, Morin D, Nishio S, Buckpitt A: Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene. The Journal of pharmacology and experimental therapeutics 1992, 261(1):353-363. 11. Carratt SA, Morin D, Buckpitt AR, Edwards PC, Van Winkle LS: Naphthalene cytotoxicity in microsomal epoxide hydrolase deficient mice. Toxicology Letters 2016, 246:35-41. 12. Pakenham G, Lango J, Buonarati M, Morin D, Buckpitt A: Urinary Naphthalene Mercapturates as Biomarkers of Exposure and Stereoselectivity of Naphthalene Epoxidation. Drug Metabolism and Disposition 2002, 30(3):247. 13. Waidyanatha S, Troester MA, Lindstrom AB, Rappaport SM: Measurement of hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone after administration of naphthalene to F344 rats. Chemico-Biological Interactions 2002, 141(3):189-210. 14. Hong JH, Lee WC, Hsu YM, Liang HJ, Wan CH, Chien CL, Lin CY: Characterization of the biochemical effects of naphthalene on the mouse respiratory system using NMR-based metabolomics. Journal of applied toxicology : JAT 2014, 34(12):1379-1388. 15. Ling YS, Liang HJ, Chung MH, Lin MH, Lin CY: NMR- and MS-based metabolomics: various organ responses following naphthalene intervention. Molecular bioSystems 2014, 10(7):1918-1931. 16. Hsieh PC: Mass Spectrometry-Based Lipidomics to Study Dose-Response Relationship of Naphthalene on Various Organs of Mice. National Taiwan University Master Thesis 2016. 17. Hong SH: Mass spectrometry-based lipidomics to explore the naphthalene toxicity in a tolerant mouse model. National Taiwan University Master Thesis 2014. 18. Chen KH: Mass Spectrometry-Based Lipidomics to Study Early Event of Naphthalene Toxicity in Mice. National Taiwan University Master Thesis 2015. 19. Pittet JF, Mackersie RC, Martin TR, Matthay MA: Biological markers of acute lung injury: prognostic and pathogenetic significance. American journal of respiratory and critical care medicine 1997, 155(4):1187-1205. 20. Ballinger CA, Brand JD, Postlethwait EM: In Vitro Systems for Studying Respiratory System Toxicology. In: Comprehensive Toxicology, Second Edition. vol. 8; 2010: 243-259. 21. Song JA, Yang HS, Lee J, Kwon S, Jung KJ, Heo JD, Cho KH, Song CW, Lee K: Standardization of Bronchoalveolar Lavage Method Based on Suction Frequency Number and Lavage Fraction Number Using Rats. Toxicological Research 2010, 26(3):203-208. 22. Henderson RF: Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaled material. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 2005, 57 Suppl 1:155-159. 23. Kang YP, Lee WJ, Hong JY, Lee SB, Park JH, Kim D, Park S, Park CS, Park SW, Kwon SW: Novel approach for analysis of bronchoalveolar lavage fluid (BALF) using HPLC-QTOF-MS-based lipidomics: lipid levels in asthmatics and corticosteroid-treated asthmatic patients. Journal of proteome research 2014, 13(9):3919-3929. 24. Dailey LA, Hernandez-Prieto R, Casas-Ferreira AM, Jones MC, Riffo-Vasquez Y, Rodriguez-Gonzalo E, Spina D, Jones SA, Smith NW, Forbes B et al: Adenosine monophosphate is elevated in the bronchoalveolar lavage fluid of mice with acute respiratory toxicity induced by nanoparticles with high surface hydrophobicity. Nanotoxicology 2015, 9(1):106-115. 25. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S et al: An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease. American journal of respiratory and critical care medicine 2012, 185(9):1004-1014. 26. Steinberg KP, Mitchell DR, Maunder RJ, Milberg JA, Whitcomb ME, Hudson LD: Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. The American review of respiratory disease 1993, 148(3):556-561. 27. Schiller J, Hammerschmidt S, Wirtz H, Arnhold J, Arnold K: Lipid analysis of bronchoalveolar lavage fluid (BAL) by MALDI-TOF mass spectrometry and 31P NMR spectroscopy. Chemistry and physics of lipids 2001, 112(1):67-79. 28. Agassandian M, Mallampalli RK: Surfactant phospholipid metabolism. Biochimica et biophysica acta 2013, 1831(3):612-625. 29. Wright JR: Immunomodulatory functions of surfactant. Physiological reviews 1997, 77(4):931-962. 30. Niden AH: Bronchiolar and Large Alveolar Cell in Pulmonary Phospholipid Metabolism, vol. 158. Science: Science; 1968. 31. Widdicombe JG, Pack RJ: The Clara cell. European journal of respiratory diseases 1982, 63(3):202-220. 32. Batenburg JJ: Surfactant phospholipids: synthesis and storage. The American journal of physiology 1992, 262(4 Pt 1):L367-385. 33. Jobe AH: Lung Development and Maturation, Neonatal-Perinatal Medicine 2002:973-977. 34. Bernhard W: Lung surfactant: Function and composition in the context of development and respiratory physiology. Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 2016, 208:146-150. 35. Gille C, Spring B, Bernhard W, Gebhard C, Basile D, Lauber K, Poets CF, Orlikowsky TW: Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages. Journal of lipid research 2007, 48(2):307-317. 36. Nkadi PO, Merritt TA, Pillers DAM: An Overview of Pulmonary Surfactant in the Neonate: Genetics, Metabolism, and the Role of Surfactant in Health and Disease. Molecular genetics and metabolism 2009, 97(2):95-101. 37. Low RB, Davis GS, Bell DY, Giancola MS, Vacek PM: Lipids in bronchoalveolar lavage fluid from patients with sarcoidosis. Thorax 1987, 42(12):926-932. 38. Baker G, Duck-Chong C, Cleland K, Berend N: The Surfactant System as an Intrinsic Monitor of Acute Interstitial Lung Disease. CHEST 1986, 89(3):126S-127S. 39. Chen WL, Lin CY, Yan YH, Cheng KT, Cheng TJ: Alterations in rat pulmonary phosphatidylcholines after chronic exposure to ambient fine particulate matter. Molecular bioSystems 2014, 10(12):3163-3169. 40. Dethloff LA, Gilmore LB, Brody AR, Hook GE: Induction of intra- and extra-cellular phospholipids in the lungs of rats exposed to silica. Biochemical Journal 1986, 233(1):111-118. 41. Fahy E, Subramaniam S, Murphy RC, Nishijima M, Raetz CR, Shimizu T, Spener F, van Meer G, Wakelam MJ, Dennis EA: Update of the LIPID MAPS comprehensive classification system for lipids. Journal of lipid research 2009, 50 Suppl:S9-14. 42. Kishimoto K, Urade R, Ogawa T, Moriyama T: Nondestructive Quantification of Neutral Lipids by Thin-Layer Chromatography and Laser-Fluorescent Scanning: Suitable Methods for “Lipidome” Analysis. Biochemical and Biophysical Research Communications 2001, 281(3):657-662. 43. Orešič M, Hänninen VA, Vidal-Puig A: Lipidomics: a new window to biomedical frontiers. Trends in Biotechnology 2008, 26(12):647-652. 44. Lagarde M, Geloen A, Record M, Vance D, Spener F: Lipidomics is emerging. Biochimica et biophysica acta 2003, 1634(3):61. 45. van Meer G, Voelker DR, Feigenson GW: Membrane lipids: where they are and how they behave. Nature Reviews Molecular Cell Biology 2008, 9:112. 46. Kent C, Carman GM: Interactions among pathways for phosphatidylcholine metabolism, CTP synthesis and secretion through the Golgi apparatus. Trends in Biochemical Sciences 1999, 24(4):146-150. 47. Wenk MR: The emerging field of lipidomics. Nature reviews Drug discovery 2005, 4(7):594-610. 48. Bhagavan NV, Ha C-E: Chapter 17 - Lipids II: Phospholipids, Glycosphingolipids, and Cholesterol. In: Essentials of Medical Biochemistry. Edited by Bhagavan NV, Ha C-E. San Diego: Academic Press; 2011: 209-223. 49. D'Avanzo N: Chapter Twelve - Lipid Regulation of Sodium Channels. In: Current Topics in Membranes. Edited by French RJ, Noskov SY, vol. 78: Academic Press; 2016: 353-407. 50. Cutler RG, Mattson MP: Sphingomyelin and ceramide as regulators of development and lifespan. Mechanisms of ageing and development 2001, 122(9):895-908. 51. Plopper CG, Van Winkle LS, Fanucchi MV, Malburg SR, Nishio SJ, Chang A, Buckpitt AR: Early events in naphthalene-induced acute Clara cell toxicity. II. Comparison of glutathione depletion and histopathology by airway location. American journal of respiratory cell and molecular biology 2001, 24(3):272-281. 52. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. The Journal of biological chemistry 1957, 226(1):497-509. 53. Tang CH, Tsao PN, Chen CY, Shiao MS, Wang WH, Lin CY: Glycerophosphocholine molecular species profiling in the biological tissue using UPLC/MS/MS. Journal of chromatography B, Analytical technologies in the biomedical and life sciences 2011, 879(22):2095-2106. 54. Tang CH, Tsao PN, Lin CY, Fang LS, Lee SH, Wang WH: Phosphorylcholine-containing lipid molecular species profiling in biological tissue using a fast HPLC/QqQ-MS method. Analytical and bioanalytical chemistry 2012, 404(10):2949-2961. 55. Pluskal T, Castillo S, Villar-Briones A, Orešič M: MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 2010, 11(1):395. 56. Vinaixa M, Samino S, Saez I, Duran J, Guinovart JJ, Yanes O: A Guideline to Univariate Statistical Analysis for LC/MS-Based Untargeted Metabolomics-Derived Data. Metabolites 2012, 2(4):775-795. 57. Worley B, Powers R: Multivariate Analysis in Metabolomics. Current Metabolomics 2013, 1(1):92-107. 58. Banerjee P, Ghosh S, Dutta M, Subramani E, Khalpada J, RoyChoudhury S, Chakravarty B, Chaudhury K: Identification of Key Contributory Factors Responsible for Vascular Dysfunction in Idiopathic Recurrent Spontaneous Miscarriage. PLOS ONE 2013, 8(11):e80940. 59. Schmidt R, Markart P, Ruppert C, Wygrecka M, Kuchenbuch T, Walmrath D, Seeger W, Guenther A: Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respiratory research 2007, 8:55. 60. Evans CR, Karnovsky A, Kovach MA, Standiford TJ, Burant CF, Stringer KA: Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health. Journal of proteome research 2014, 13(2):640-649. 61. King RJ: Pulmonary surfactant. Journal of applied physiology: respiratory, environmental and exercise physiology 1982, 53(1):1-8. 62. Vuchetich PJ, Bagchi D, Bagchi M, Hassoun EA, Tang L, Stohs SJ: Naphthalene-induced oxidative stress in rats and the protective effects of vitamin E succinate. Free radical biology & medicine 1996, 21(5):577-590. 63. Schmidt R, Luboeinski T, Markart P, Ruppert C, Daum C, Grimminger F, Seeger W, Gunther A: Alveolar antioxidant status in patients with acute respiratory distress syndrome. The European respiratory journal 2004, 24(6):994-999. 64. Smith HL, Howland MC, Szmodis AW, Li Q, Daemen LL, Parikh AN, Majewski J: Early stages of oxidative stress-induced membrane permeabilization: a neutron reflectometry study. Journal of the American Chemical Society 2009, 131(10):3631-3638. 65. Martinez-Seara H, Róg T, Karttunen M, Reigada R, Vattulainen I: Influence of cis double-bond parametrization on lipid membrane properties: How seemingly insignificant details in force-field change even qualitative trends. The Journal of Chemical Physics 2008, 129(10):105103. 66. Dean JM, Lodhi IJ: Structural and functional roles of ether lipids. Protein & cell 2018, 9(2):196-206. 67. Kobayashi T, Shinnoh N, Kondo A, Yamada T: Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 1997, 232(3):631-636. 68. Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD: A mouse model for X-linked adrenoleukodystrophy. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(17):9366-9371. 69. Wanders RJ, Brites P: Biosynthesis of ether-phospholipids including plasmalogens, peroxisomes and human disease: new insights into an old problem. Clinical Lipidology 2010, 5(3):379-386. 70. Lessig J, Fuchs B: Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Current medicinal chemistry 2009, 16(16):2021-2041. 71. Rudiger M, Kolleck I, Putz G, Wauer RR, Stevens P, Rustow B: Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures. The American journal of physiology 1998, 274(1 Pt 1):L143-148. 72. Tölle A, Meier W, Greune G, Rüdiger M, Peter Hofmann K, Rüstow B: Plasmalogens reduce the viscosity of a surfactant-like phospholipid monolayer. Chemistry and physics of lipids 1999, 100(1):81-87. 73. Qamar W: Technical considerations and precautions in in situ bronchoalveolar lavage and alveolar infiltrating cells isolation in rats. Toxicology mechanisms and methods 2015, 25(7):547-551. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72244 | - |
dc.description.abstract | 萘廣泛存在於環境中,被美國環保署訂為人類可能性致癌物。先前的研究發現萘的急性暴露會導致小鼠呼吸系統的毒性,對克氏細胞造成囊泡化和腫脹等情形,同時改變細胞膜的通透性,並具有劑量效應性。肺部灌洗液(Bronchoalveolar lavage fluid)中除含有免疫細胞外,還有表面活性劑(surfactant)相關的脂質、磷脂質和蛋白質。因此肺部灌洗液中的分子組成可以提供有價值的資訊,反應肺部的的生化改變。然而因為技術上的考量,肺部灌洗液的脂質研究數量仍然相當稀少。因此本研究希望透過脂質體學的方法探討肺部灌洗液中脂質體的改變來了解萘引發的肺部毒性。
本研究使用七週大的雄性ICR小鼠,並分為三組,控制組是將小鼠利用腹腔內注射施予橄欖油,低劑量與高劑量組則分別使用腹腔內注射施予使用含有萘劑量100或200 mg/kg body weight的橄欖油,暴露後24小時後麻醉犧牲,並抽取肺部灌洗液。經脂質萃取等前處理後,利用極致高效液相層析串聯式質譜儀分析含有磷酸膽鹼的脂質,包含磷脂醯膽鹼(phosphatidylcholine)和神經磷脂(sphingomyelin)。得到的圖譜數據經過前處理之後,再利用偏最小平方判別等方法進行多變量統計分析和單變量統計分析來評估萘所引發的脂質擾動。 偏最小平方判別法中的分數圖顯示控制組、低劑量、高劑量三組的脂質體散布在不同的區域,並且有明顯的分離。PC(16:0/16:0)和PC(16:0/14:0)兩種脂質在高劑量組有下降的趨勢,推測和表面活性劑(surfactant)的功能有關,多種磷脂醯膽鹼(diacyl-phosphatidylcholines, plasmanylcholines 和 plasmenylcholines)在高劑量組有上升趨勢,則推測和抗氧化作用等保護作用有關。因此,利用質譜儀為基礎的脂質體學研究,可以發現到小鼠暴露到萘之後,肺部灌洗液中的脂質變化,幫助我們了解呼吸系統萘的毒性機制,並可以進一步應用在生物指標的開發上。 | zh_TW |
dc.description.abstract | Naphthalene, as a suspected carcinogen listed by the US Environmental Protection Agency, widely exists in the environment. Previous studies indicated that naphthalene caused acute respiratory toxicity in mice. Acute exposure to naphthalene induced swelling and vacuolation of Clara cells and altered membrane integrity with dose-response effects. Lipidomic analysis of respiratory system may help us realize naphthalene-induced toxicity.
Bronchoalveolar lavage fluid (BALF) consists of inflammatory cells and acellular components such as surfactant-like lipids, phospholipids and proteins. The molecular composition of the fluid provides valuable information of biochemical alterations in the lungs. However, limited numbers of studies examined the lipid constituent of BALF due to technical limitation. In the present study, we aim to study the respiratory toxicity of naphthalene by measuring lipid components in BALF. 7-week male ICR mice were randomly divided into 3 groups (n=6), treated with olive oil (control) or naphthalene (100, 200 mg/kg body weight in olive oil) by intraperitoneal injection. After 24 hr., mice were anesthetized and BALF were collected for further analysis. Lipidomics, a platform able to examine considerable lipids at the same time, can provide integrated information of biological changes induced by environmental stimuli. In this study, phosphorylcholine-containing lipids, such as phosphatidylcholine and sphingomyelin, were profiled by ultra-performance liquid chromatography tandem mass spectrometer (UPLC-MS/MS). The MS spectra were further processed and analyzed by partial least squares discriminant analysis (PLS-DA). The PLS-DA score plot showed that lipidome of control, low-dose, and high-dose groups were separated clearly. Moreover, the responses of the low-dose and high-dose groups are different; possibly indicated that different mechanisms were involved. Decreasing level of PC(16:0/16:0) and PC(16:0/14:0) after mice treated with high-dose naphthalene may be related with function of surfactant. Besides, increasing level of diacyl-phosphatidylcholines, plasmanylcholines, and plasmenylcholines after mice treated with high-dose naphthalene may be associated with anti-oxidation and protective mechanisms. We concluded that MS-based lipidomics is a powerful tool to exhibit lipid perturbation in BALF, helping us to understand the toxic mode of actions of naphthalene in the respiratory system and develop biomarkers. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T06:31:00Z (GMT). No. of bitstreams: 1 ntu-107-R05844004-1.pdf: 1543632 bytes, checksum: 5433926b02f30c883be86d58d6b806a5 (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 致謝 i
摘要 ii Abstract iii Contents v List of figures vii List of tables viii 1. Introduction 1 1.1 Background 1 1.2 Environmental fate of naphthalene 1 1.3 Dose-dependent naphthalene toxicity in animal models 2 1.4 Naphthalene metabolism and reactive metabolites 2 1.5 Bronchoalveolar lavage fluid 3 1.6 Pulmonary Surfactant 4 1.7 Lipidomics 5 1.8 Phosphorylcholine-containing lipids 6 1.9 Study aims 8 2. Materials and methods 10 2.1 Experiment flow chart 10 2.2 Animal handling 11 2.3 Lipid extraction 11 2.4 Phosphorylcholine-containing lipid profiling by UPLC-MS/MS 12 2.5 Structural identification by UPLC-MS/MS 13 2.6 Data preprocessing 15 2.7 Analytical variation handling 15 2.8 Multivariate data analysis 16 2.9 Univariate analysis 17 3. Results 18 3.1 BALF lipid profiling by UPLC-MS/MS 18 3.2 Effects of naphthalene on BALF phosphorylcholine-containing lipids in multivariate analysis 19 3.3 Effects of naphthalene on BALF phosphorylcholine-containing lipids in univariate analysis 19 4. Discussion 21 4.1 Decreasing levels of surfactant lipids after high-dose naphthalene treatment 21 4.2 Increasing levels of polyunsaturated diacyl-PCs after high-dose naphthalene treatment 23 4.3 Increasing levels of ether-linked PCs after high-dose naphthalene treatment 24 4.4 Naphthalene-induced changes of SMs 25 4.5 More noticeable changes after 200 mg/kg of naphthalene treatment 26 4.6 Lipidome comparison between BALF and lung 27 4.7 Limitation and future work 28 5. References 30 Appendix 52 | |
dc.language.iso | en | |
dc.title | 應用質譜分析小鼠肺部灌洗液的脂質體研究萘引發的呼吸系統毒性 | zh_TW |
dc.title | Mass Spectrometry-Based Lipidomics to Characterize Naphthalene-Induced Respiratory Toxicity on Bronchoalveolar Lavage Fluid of Mice | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 唐川禾,鄭尊仁 | |
dc.subject.keyword | 脂質體學,?,質譜儀,肺部灌洗液,毒性,磷脂醯膽鹼,神經磷脂, | zh_TW |
dc.subject.keyword | Lipidomics,Phosphorylcholine-containing lipids,Mass spectrometry,Naphthalene,Bronchoalveolar lavage fluid,Toxicity, | en |
dc.relation.page | 52 | |
dc.identifier.doi | 10.6342/NTU201803516 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-16 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 環境衛生研究所 | zh_TW |
顯示於系所單位: | 環境衛生研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 1.51 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。